Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products

Transfusion

Volumn 55, Issue 2, 2015, Pages 337-347

  Pohler, Petra ^a   Müller, Meike ^b   Winkler, Carla ^b   Schaudien, Dirk ^b   Sewald, Katherina ^b   Müller, Thomas H ^a   Seltsam, Axel ^a  

^a Institute Springe   (Germany)

^b FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; THROMBOCYTE CONCENTRATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE FUNCTION; LEUKOCYTE INACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REDUCTION; THROMBOCYTE TRANSFUSION; ULTRAVIOLET C RADIATION; ANIMAL; BLOOD SAFETY; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; GAMMA RADIATION; GRAFT VS HOST DISEASE; LEUKAPHERESIS; MALE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; THROMBOCYTE; ULTRAVIOLET RADIATION;

ANIMALS; BLOOD PLATELETS; BLOOD SAFETY; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GAMMA RAYS; GRAFT VS HOST DISEASE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MICE; MICE, INBRED NOD; PLATELET TRANSFUSION; ULTRAVIOLET RAYS;

EID: 84923081425     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12836     Document Type: Article

References (34)

1. Webert KE, Cserti CM, Hannon J, et al. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008; 22: 1-34.
2. Seltsam A, Muller TH,. Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 2013; 162: 442-454.
3. Ohto H,. Gamma radiation does not prevent transfusion-induced HLA alloimmunization. Transfusion 1997; 37: 878-879.
4. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44: 25-29.
5. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44: 16-24.
6. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44: 10-15.
7. Mohr H, Steil L, Gravemann U, et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009; 49: 2612-2624.
8. Seltsam A, Müller TH,. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011; 38: 43-54.
9. Douki T, Laporte G, Cadet J,. Inter-strand photoproducts are produced in high yield within A-DNA exposed to UVC radiation. Nucleic Acids Res 2003; 31: 3134-3142.
10. Mohr H, Gravemann U, Bayer A, et al. Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009; 49: 1956-1963.
11. Goes EG, Borges JC, Covas DT, et al. Quality control of blood irradiation: determination T cells radiosensitivity to cobalt-60 gamma rays. Transfusion 2006; 46: 34-40.
12. Pelszynski MM, Moroff G, Luban NL, et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83: 1683-1689.
13. King MA, Covassin L, Brehm MA, et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157: 104-118.
14. Ruehl-Fehlert C, Kittel B, Morawietz G, et al.; RITA Group; NACAD Group. Revised guides for organ sampling and trimming in rats and mice - Part 1. Exp Toxicol Pathol 2003; 55: 91-106.
15. Kittel B, Ruehl-Fehlert C, Morawietz G, et al.; RITA Group; NACAD Group. Revised guides for organ sampling and trimming in rats and mice-Part 2. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 2004; 55: 413-431.
16. Morawietz G, Ruehl-Fehlert C, Kittel B, et al.; RITA Group; NACAD Group. Revised guides for organ sampling and trimming in rats and mice-Part 3. A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 2004; 55: 433-449.
17. Luban NL,. Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Semin Hematol 2001; 38: 34-45.
18. Sinha RP, Hader DP,. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 2002; 1: 225-236.
19. Lee TH, Reed W, Mangawang-Montalvo L, et al. Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 2001; 41: 637-642.
20. Kiefel V, Konig C, Kroll H, et al. Platelet alloantibodies in transfused patients. Transfusion 2001; 41: 766-770.
21. Claas FH, Smeenk RJ, Schmidt R, et al. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol 1981; 9: 84-89.
22. Fast LD, Nevola M, Tavares J, et al. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 2013; 53: 373-381.
23. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999; 93: 3140-3147.
24. Jackman RP, Heitman JW, Marschner S, et al. Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion 2009; 49: 2686-2699.
25. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 625-628.
26. Stack G, Snyder EL,. Cytokine generation in stored platelet concentrates. Transfusion 1994; 34: 20-25.
27. Kluter H, Bubel S, Kirchner H, et al. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39: 1179-1184.
28. Apelseth TO, Hervig TA, Wentzel-Larsen T, et al. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 2006; 46: 800-810.
29. Picker SM, Steisel A, Gathof BS,. Evaluation of white blood cell- and platelet-derived cytokine accumulation in MIRASOL-PRT-treated platelets. Transfus Med Hemother 2009; 36: 114-120.
30. Gravemann U, Pohler P, Mueller TH, et al. In vitro quality of platelets treated in the THERAFLEX UV-Platelets system is well preserved during storage. Vox Sang 2013; 105 (Suppl 1): 134.
31. Ahmed KA, Xiang J,. Mechanisms of cellular communication through intercellular protein transfer. J Cell Mol Med 2011; 15: 1458-1473.
32. Otani T, Toraya T, Sugimoto A, et al. Marked induction of CD4+CD8+ T cells with multifunctional properties by coculturing CD2+ cells with xenogeneic stromal cells. J Immunol Methods 2011; 372: 78-88.
33. Asano H, Lee CY, Fox-Talbot K, et al. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007; 84: 1174-1182.
34. Marschner S, Fast LD, Baldwin Iii WM, et al. White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion 2010; 50: 2489-2498.